DEOGEN2

DEOGEN2 predicts the deleteriousness of amino acid variants in human proteins to assess their potential impact on human health.

Key Features:

• Integration of heterogeneous data: Incorporates molecular effects, protein domains, gene relevance, and interaction networks to evaluate variant impact on protein function.
• Non-linear mapping to deleteriousness score: Uses advanced algorithms to non-linearly combine contextual information into a single interpretable deleteriousness score that quantifies the likelihood of adverse effects.

Scientific Applications:

• Variant interpretation in genetic research: Distinguishes between deleterious and benign amino acid changes to support studies of genotype–phenotype relationships.
• Clinical variant assessment: Assesses variant pathogenicity to inform clinical genetic diagnostics and variant classification.
• Disease mechanism and target discovery: Aids investigation of disease mechanisms and identification of candidate targets for therapeutic intervention.

Methodology:

Integrates diverse data sources on genetic variation and protein function—including molecular effects, domain involvement, gene significance, and interaction networks—and applies a non-linear mapping approach to produce a deleteriousness score.